Scopia Surgical, a medical technology startup developing real-time AI-powered surgical navigation software, Scopia Surgical Navigation, for minimally invasive and robotic surgery, has closed a $2.65 million CAD pre-seed round.
Linearis Ventures and Anges Quebec co-led the pre-seed investment round with participation from Fonds Impulsion, HaloHealth, Richard Rubin, Suresh Madan, and other investors.
“This round, backed by investors who have built and scaled life sciences companies, gives us the resources and expert advisory needed to bring our vision into the first clinical evaluations”, said Gabriel Rivest, CEO and co-founder.
Scaling Scopia Surgical Navigation
Scopia Surgical has confirmed that proceeds will be used to grow its engineering and clinical teams, accelerate product development efforts, and advance the clinical validation for its platform, Scopia Surgical Navigation, across several hospitals in Canada and the United States.
Building Robotic Surgical System
Scopia Surgical is building a physical AI software platform for robotic surgery. By fusing real-time spatial intelligence with patient-specific digital twins, Scopia Surgical bridges the gap between human intervention and robotic execution. The technology, based on computer vision, enables existing systems to achieve unprecedented precision, transforming the operating room into a high-fidelity, autonomous-ready environment.
The startup is now focused on preparing for the regulatory and commercialization milestones. “Our goal is to bring the full richness of preoperative imaging into the operating room, in real time on the systems hospitals already own to reduce complications and optimize surgical outcomes”, added Rivest.
Surgical navigation startups have raised billions of dollars so far this year. More recently, Dopl Technologies, a Bothell, Washington-based medical technology startup developing a robotic ultrasound platform, closed a $6.3 million seed round, bringing its total funding to date to more than $8 million.
In another deal, SquareMind, a France-based robotics startup developing AI-powered dermatology solutions to make high-quality skin exams more efficient and accessible, raised $18 million in a pre-Series A funding round.
Latest News:
- Inner Logic Lands $11.5M Seed Round for Autonomous Surgery Infrastructure
- Hypervision Surgical Raises £17M Series A Round to Power Future Surgical Insights
The pre-seed funding transitions Scopia Surgical from an early-stage development phase into a cross-border regulatory pipeline. The startup is now allocating more resources to advance its first clinical validations across a network of partner hospitals in both Canada and the United States. These active multi-center assessments are designed to generate the peer-reviewed data required for upcoming regulatory filings and early commercial licensing.
“The momentum behind this oversubscribed financing reflects our confidence in Scopia’s vision and its ability to unlock the transformative potential of physical AI within one of healthcare’s fastest-growing markets. We believe Scopia could become a category-defining company”, according to Manon Boisclair, Managing Partner, Linearis Ventures.